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Abstract
Background Laparoscopic ventral rectopexy has been used
to treat male patients with external rectal prolapse, but
evidence to support this approach is scarce. The aim of this
study was to evaluate the results of this new abdominal
rectopexy surgical technique in men.
Methods This was a retrospective multicenter study. Adult
male patients who were operated on for external rectal
prolapse using ventral rectopexy in five tertiary hospitals in
Finland between 2006 and 2014 were included in the study.
Patient demographics, detailed operative, postoperative
and short-term follow-up data were collected from patient
registers in participating hospitals. A questionnaire and
informed consent form was sent to all patients. The ques-
tionnaire included scores for anal incontinence, obstructed
defecation syndrome, urinary symptoms and sexual dys-
function. The main outcome measure was the incidence of
recurrent rectal prolapse. Surgical morbidity, the need for
surgical repair due to recurrent symptoms and functional
outcomes were secondary outcome measures.
Results A total of 52 adult male patients with symptoms
caused by external rectal prolapse underwent ventral
rectopexy. The questionnaire response rate was 64.4 %.
Baseline clinical characteristics and perioperative results
were similar in the responder and non-responder groups.
A total of 9 (17.3 %) patients faced complications. There
were two (3.8 %) serious surgical complications during
the 30-day period after surgery that necessitated reoper-
ation. None of the complications were mesh related.
Recurrence of the prolapse was noticed in nine patients
(17 %), and postoperative mucosal anal prolapse symp-
toms persisted in 11 patients (21 %). As a result, the
reoperation rate was high. Altogether, 17 patients (33 %)
underwent reoperation during the follow-up period due to
postoperative complications or recurrent rectal or mucosal
prolapse. According to the postoperative questionnaire
data, patients under 40 had good functional results in
terms of anal continence, defecation, urinary functions
and sexual activity.
Conclusions Laparoscopic ventral rectopexy is a safe
surgical procedure in male patients with external prolapse.
However, a high overall reoperation rate was noticed due
to recurrent rectal and residual mucosal prolapse. This
suggests that the ventral rectopexy technique should be
modified or combined with other abdominal or perineal
methods when treating male rectal prolapse patients.
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Introduction
Over the years, more than 100 different procedures have
been described for the treatment of external rectal prolapse
(ERP), but the optimal surgical approach has not yet been
determined [1]. Since ERP is a rare condition in males [2],
few studies have been conducted on the different treatment
modalities. ERP diminishes the quality of life (QoL)
remarkably. Almost without exception, it is associated with
anal incontinence and constipation. Therefore, the majority
of patients seek medical help [2]
Because of the risk of autonomic nerve damage during
pelvic dissection, the traditional approach to ERP in men
has been perineal [3]. Abdominal rectopexy techniques are
the gold standard for the treatment of full-thickness ERP
because they are associated with a lower rate of long-term
recurrence than perineal procedures [3–5]. D’Hoore and
Penninckx described a new autonomic nerve-sparing
laparoscopic ventral rectopexy technique (LVR) for ERP
[6], which is also widely used for internal rectal prolapse,
enterocele and rectocele regardless of the fact that there is
only Level 3 evidence to support its use in circumstances
other than ERP [4].
Structural abnormalities of the pelvic floor are more
common in female patients, andmost of the data available on
the effectiveness in LVR is based on operations performed
on female patients [7–9]. LVR has also been used to treat
male patients with ERP [10], although the evidence to sup-
port this approach is lacking. To our knowledge, only one
study has provided results in male patients [11]. A panel of
experts has stated that both sexes should be considered
suitable for LVR in cases of ERP [12]. During the data col-
lection phase in a national multicenter study, it emerged that
in every participating Finnish hospital, male patients with
ERP were treated using the original D’Hoore technique. In
this paper, our study group reports the long-term success
rates and functional outcome of these operations.
Materials and methods
Study population and data collection
All adult male patients who were operated on for external
rectal prolapse using ventral rectopexy in five tertiary
hospitals in Finland during 2006–2014 were included in the
study. The study was approved by the local ethics com-
mittee of each hospital. Data were collected from patient
registers in participating hospitals, and procedures were
identified by their operation codes. Patient demographics
and clinical data were recorded, including age, body mass
index (BMI), American Society of Anesthesiologists
(ASA) class and symptoms caused by ERP. The collected
operative details were details of surgical technique, oper-
ation time, blood loss and perioperative complications and
their management. The 30-day morbidity and mortality and
the length of hospital stay were also noted.
Surgical technique
In each hospital, experienced surgeons performed the oper-
ations. Surgical technique primarily followed the protocol
described by D’Hoore et al. [6]. Some of the surgeons made
minor modifications to the original procedure. The pelvic
peritoneum was opened mainly with diathermy scissors or
with the Harmonic Scalpel TM (Johnson & Johnson, Ethicon
Endosurgery) to avoid damaging the hypogastric nerves. The
rectal wall was exposed through the deepest part of the rec-
tovesical pouch and under the Denonvilliers fascia. The
choice of the syntheticmeshwas determined according to the
surgeon’s preference and experience of each surgeon. For the
fixation of the mesh to the sacral promontory, spiral attach-
ments (Pro-TackTM Fixation Device, Covidien) were used
through the lower right quadrant or an additional subrapubic
trocar. The peritoneum was closed over the mesh with
interrupted or continuous sutures. For the robotic operations
with the da Vinci Surgical System (Intuitive Surgical Inc.
Sunnyvale CA, USA), side docking with five trocar place-
ments was used. Perioperative carewas conducted according
to the enhanced recovery after surgery (ERAS) protocol.
Follow-up and questionnaires
Follow-up data were collected from patient registers, where
the information about the outpatient clinic visits and
reoperations was noted. A questionnaire and informed
consent form were sent to all patients. The questionnaire
included the Wexner Continence Grading Scale [13] for
incontinence symptoms and the obstructive defecation
score [14] for constipation/obstructed defecation syndrome
(ODS) symptoms. Patients reported the incontinence and
obstructive defecation/constipation-related symptoms on a
visual analogue scale (VAS) (1–10: no discomfort–great
discomfort). The change from before after the operation in
terms of symptoms and the impact of symptoms on QoL
were likewise reported on a simple VAS scale (1–10: much
worse–much better). The patients were asked about de
novo symptoms related to urinary incontinence, incomplete
bladder emptying, pelvic pain and loss of urge to defecate,
and they were also free to comment on additional symp-
toms. There were specific questions concerning the impact
of the operation on sexual function and on symptoms
before surgery. A validated international index for erectile
function (IIEF)-6 [15] and the International Prostate
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Symptom Score (IPSS) [16)] were used to assess the pos-
sible impact of the operation on sexual and urinary func-
tion. The preoperative–postoperative change regarding
each symptom was assessed using a VAS scale (1–10:
much better–much worse). Finally, the patients were asked
whether they were satisfied with the surgical results (yes/
no/cannot say). A reminder questionnaire was sent to those
who did not respond to the first one in order to improve the
response rate.
Statistical analysis
Summary measurements are presented as mean with stan-
dard deviation (SD). Between group comparisons were
performed using Student’s t test (continuous data) and
Fisher’s exact test or Pearson’s v2-test (categorical data).
Two-tailed p values are reported. A p value \0.05 was
considered statistically significant. Data were analyzed
using SPSS for windows (IBM Corp. Released 2012. IBM
SPSS Statistics for Windows, Version 21.0. Armonk, NY,
USA: IBM Corp.).
Results
Fifty-two adult male patients with a mean age of
46.2 years ± 18.6 underwent surgery. The indication for
operation was symptoms caused by the external rectal
prolapse. Three patients died during follow-up: one due to
hepatic cirrhosis and two due to accidents. There were two
patients with severe mental retardation who could neither
give their informed consent nor fill in the questionnaire
forms. Two patients lacked contact information. Conse-
quently, 45 questionnaire letters were sent and 29 were
returned, resulting in a response rate of 65 %. Baseline
clinical characteristics were similar in the responder and
non-responder groups (Table 1). The perioperative results
did not differ between these groups either in terms of
complications or recurrence (Table 2).
Four patients were operated on because of recurrent
prolapse: two patients after suture rectopexy and one
patient after dorsal and ventral rectopexy. Two patients
underwent a modified LVMR. In one operation, a tech-
nique described by Sileri was used; in another operation, a
combined posterior suture rectopexy was performed. Other
operative details are shown in Table 2. Conversion to open
surgery occurred in three obese patients due to prolonged
operating time. Intraoperative bleeding was minor, and the
perioperative complications were rare. A total of nine
(17 %) patients experienced minor complications. Only
two reoperations were performed due to immediate post-
operative complications (bleeding and occlusion). There
were no mesh-related complications or postoperative
60-day mortality. The mean operative time was
114 ± 36 min, and the in-hospital stay was 3 ± 1.6 days.
A recurrence of the prolapse was noticed in nine patients
(17 %), and postoperative mucosal anal prolapse symp-
toms were noticed in 11 patients (21 %). Altogether 17
(33 %) patients were operated on because of postoperative
complications (n = 2), recurrent rectal (n = 7) or mucosal
(n = 8) prolapse (Table 3).
Functional outcomes
As we did not have any preoperative functional data, it was
not possible to evaluate the individual benefit of the
operation for the patient. The mean follow-up time was
4.7 years (range 1.9–10.7 years). According to postopera-
tive questionnaire data, patients under 40 had no major
problems with anal continence or defecation. In the group
of patients over 40, Wexner and ODS scores and VAS for









Age (years) 46.2 (SD 18.6) 46.5 (SD 18.6) 45.5 (SD 18.6)
Body mass index 25.6 (SD 4.6) 24.8 (SD 3.8) 26.5 (SD 5.0)
ASA class
1 22 (42.3) 13 (44.8) 9 (39.1)
2 17 (32.7) 9 (31.0) 8 (34.8)
3 13 (25.0) 7 (24.1) 13 (25.0)
Previous abdominal operation 14 (26.9) 7 (24.1) 7 (30.4)
Reoperation for prolapse 4 (7.7) 2 (6.9) 2 (8.7)
Follow-up time (months) 56.1 (SD 22.5) 55.2 (SD 23.7) 57.2 (SD 21.4)
Nominal variables are reported as counts and percentages (in parentheses); continuous variables are
reported as mean and standard deviation
ASA American Society of Anesthesiologists, SD standard deviation
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higher (Table 4). The same trend was seen in terms of
QoL, sexual activity, IIEF-6 and IPSS scores in these two
age groups (Table 4).
Discussion
The present study showed that the ventral rectopexy in
male patients with total rectal prolapse often results in
reoperations due to recurrence and mucosal prolapse. In
addition, the complication rate was significantly higher
than in the study by Owais et al. [11]. However, there were
no serious surgical or mesh-related complications, indi-
cating that ventral rectopexy can therefore be considered as
a safe procedure in male patients.
The current study was limited by its small size and lack
of preoperative functional data. Furthermore, the response
rate to our questionnaires was quite low (65 %). Therefore,
we could not report reliable symptom relief data. However,
as the mean follow-up time was almost 5 years, the overall






Operation type, n (%)
Laparoscopic 43 (82.7) 25 (86.2)
Robotic 9 (17.3) 4 (13.8)
Modified technique, n (%) 2 (3.8) 2 (6.9)
Instrument used, n (%)
Monopolar scissors 24 (46.2) 12 (41.4)
Harmonic scalpel 25 (48.1) 14 (38.3)
Ligasure 2 (3.8) 1 (3.4)
Missing 1 0
Mesh type, n (%)
Polypropylene 16 (30.8) 8 (27.6)
Polyester 35 (67.3) 20 (69.0)
Biological implant 1 (1.9) 1 (3.4)
Mesh fixation, n (%)
Rectum only 48 (92.3) 27 (93.1)
Levator muscle 4 (7.7) 2 (6.9)
Number of sutures, n (%)
3–5 14 (26.9) 8 (27.6)
6–8 22 (42.3) 12 (41.4)
9–14 16 (30.8) 9 (31.0)
Operation time (min), mean (SD) 114 (SD 36); n = 37 112 (SD 27); n = 21
Blood loss (ml), mean (SD) 38 (SD 69); n = 24 48 (SD 85); n = 15
In-hospital stay (days), mean (SD) 3.0 (SD 1.6); n = 50 2.8 (SD 1.4); n = 28
Conversion to open, n (%) 3 (5.7) 2 (6.9)
Postoperative complications total, n (%) 9 (17.3) 5 (17.2)
Pneumonia 1 (1.9) 1 (3.4)
Urinary tract infection 1 (1.9) 1 (3.4)
Urinary retention 2 (3.8) 1 (3.4)
Bleeding 2 (3.8) 2 (6.9)
Intestinal occlusion 1 (1.9) 1 (3.4)
Abdominal pain 1 (1.9) 1 (3.4)
Vas deferens damage 1 (1.9) 1 (3.4)
Recurrence, n (%) 9 (17.3) 5 (17.2)
Mucosal prolapse, n (%) 11 (21.2) 4 (13.8)
Nominal variables are reported as counts and percentages (in parentheses); continuous variables are
reported as mean and standard deviation. Modified technique: combined posterior rectopexy and Sileri’s
technique
SD standard deviation
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success rate was high (83 %), and most of the patients were
satisfied with the surgical treatment. The outcome of the
rectopexy surgery can be regarded as satisfactory.
According to the questionnaire data, the functional results
were good, especially in those under 40 without urinary or
sexual dysfunction. The mean IIEF-6 score indicated that
erectile function remained good among patients under 40,
based on previous IIEF-6 validation, demonstrating similar
IIEF-6 scores among younger men [15]. However, we did
not take into account of the use of erectile function in
improving medical treatment, which may impact the
results. According to the mean IPSS score, men under 40
had only mild symptoms, whereas men over 40 had mod-
erate symptoms [16]. In the general population, approxi-
mately 90 % of men under 40 have no symptoms or mild
symptoms based on IPSS score [17]. Thus, it seems that
ventral rectopexy does not cause significant voiding prob-
lems. It should be noted that the preoperative functional
results presumably are suboptimal in the older age group
([40 years) in comparison to the younger age group
(\40 years). Therefore, the postoperative results should be
worse in the older age group, as shown in this study.
The only previous study presenting results of ventral
rectopexy surgery exclusively in male patients reported
excellent outcomes [11]. There was no recurrent external
rectal prolapse, and only 8.8 % pf patients had persisting
symptoms. Owais et al. did not report any cases of long-
term impotence, retrograde ejaculation or urinary dys-
function. Altogether, the results of this single-center study
differ significantly from the outcomes of our study.
Our median operation time was double that of the
aforementioned study. The reason for the discrepancy
between these two studies might be differences in patient
groups and operative technique. In the study by Owais
et al., there were only 18 patients with external prolapse;
most of the patients (50/68) had internal prolapse with
ODS symptoms. In the participating five Finnish hospitals,




Reoperation for complication n (%) 2 (3.8)
Reoperation for prolapse n (%) 7 (13.5)
Re-LVRP 1 (1.9)
Posterior mesh rectopexy 2 (3.8)
Resection rectopexy 2 (3.8)
Perineal resection 1 (1.9)
STARR 1 (1.9)
Reoperation for mucosal prolapse n (%) 8 (15.4)
PPH 2 (3.8)
HAL, RAR/THD 4 (7.7)
Diathermy hemorrhoidectomy 2 (3.8)
Nominal variables are reported as counts and percentages (in paren-
theses); Continuous variables are reported as the mean and standard
deviation
LVRP laparoscopic ventral rectopexy, STARR stapled transanal rectal
resection, PPH procedure for prolapse and hemorrhoids, HAL hem-
orrhoidal arterial ligation, RAR rectoanal repair; THD transanal
hemorrhoidal dearterialization






Wexner score 1.7 (SD 1.5) 7.1 (SD 7.4) 0.018
VAS incontinence 1.5 (SD 2.3) 4.6 (SD 3.9) 0.027
ODS score 4.9 (SD 6.4) 13.0 (SD 6.8) 0.004
VAS ODS 1.9 (SD 2.3) 4.5 (SD 3.2) 0.020
Postoperative symptoms VAS 8.6 (SD 2.0) 5.6 (SD 3.2) 0.005
Postoperative quality of life VAS 8.6 (SD 2.3) 5.5 (SD 3.0) 0.005
Contentment with sexual activity 7.3 (SD 1.8) 4.6 (SD 3.1) 0.028
VAS 6.3 (SD 2.5) 4.1 (SD 2.3) 0.28
Postoperative urinary incontinence 7.2 (SD 3.1) 4.2 (SD 1.3) 0.40
Postoperative urinary retention 7.5 (SD 2.7) 4.7 (SD 2.2) 0.35
Postoperative pelvic pain
IIEF-6 score 25.0 (SD 8.7) 17.1 (SD 12.3) 0.079
IPSS score 5.0 (SD 4.4) 10.6 (SD 8.6) 0.037
Nominal variables are reported as counts and percentages (in parentheses); Continuous variables are
reported as the mean and standard deviation
VAS visual analogue scale; pain severity was estimated by the VAS scale f (1–10), ODS obstructed
defecation syndrome, IIEF international index for erectile function, IPSS international prostate symptom
score, SD standard deviation
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panel, symptomatic internal rectal prolapse in male patients
is not a clear indication for ventral rectopexy surgery [12].
In our study, we present the results of the largest series of
ERP in male patients. In previously published studies,
surgical outcomes have not been analyzed separately in
males and females; therefore, it is difficult to compare the
results of this study to previous studies [5–9].
Conclusions
Our results showed that LVRP is a safe in male patients
with external rectal prolapse. However, the overall reop-
eration rate was high because of recurrent rectal prolapse as
well as residual mucosal prolapse, suggesting that LVRP
should be modified or combined with another abdominal or
perineal technique. As rectal prolapse is rare in males,
randomized international multicenter studies comparing
different techniques are needed in order to find the optimal
procedure for this patient group.
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